uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia (AML) · T Lymphoblastic Leukemia/Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Wang Jianxiang) · wangjx@ihcams.ac.cn · 022-23909120
Contact: Principal Investigator (Wang Ying)

Study leads

Jianxiang Wang
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Ghent, Belgium · Paris, France

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

Acute Lymphoblastic Leukemia · Acute Leukemias · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Manchester, United Kingdom

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States